Congress trades
Medpace Holdings, Inc. (MEDP)
About Medpace Holdings, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Chief executive
- August James Troendle
- Employees
- 6,500
- Listed since
- Aug 11, 2016
- Market value
- $16.4B
- Price to earnings
- 33.7
- Earnings per share
- $17.36
- Dividend yield
- -
Earnings
6 reported quarters · next on Oct 28, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 22, 2026 | $4.25 | $3.98 | $707.3M | $689.5M | EPS beatRevenue beat |
| Q1 FY2026reported Apr 22, 2026 | $4.28 | $3.92 | $706.6M | $697.6M | EPS beatRevenue in line |
| Q4 FY2025reported Feb 9, 2026 | $4.67 | $4.19 | $708.5M | $689.3M | EPS beatRevenue beat |
| Q3 FY2025reported Oct 22, 2025 | $3.86 | $3.53 | $659.9M | $641.0M | EPS beatRevenue beat |
| Q2 FY2025reported Jul 21, 2025 | $3.10 | $2.98 | $603.3M | $538.8M | EPS beatRevenue beat |
| Q1 FY2025reported Apr 21, 2025 | $3.67 | $3.06 | $558.6M | $526.3M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 1, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| August J. TroendleChief Executive Officer Kevin M. Brady, Chief Financia | $937K | $0 | $10.5M | $11.4M |
| Stephen P. EwaldGeneral Counsel and Corporate Secretary | $710K | $0 | $2.0M | $2.7M |
| Susan E. BurwigExecutive Vice President, Operations | $642K | $0 | $1.8M | $2.4M |
| Jesse J. GeigerPresident | $460K | $0 | $1.2M | $1.6M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $1.3B | 2,498,248 | +1.1% | 8.83% |
| Price T Rowe Associates Inc | $1.1B | 2,069,677 | +614.9% | 7.31% |
| AQR Capital Management LLC | $677.3M | 1,278,935 | -5.5% | 4.52% |
| Vanguard Portfolio Management LLC | $600.2M | 1,133,357 | +1.0% | 4.00% |
| Vanguard Capital Management LLC | $543.8M | 1,026,820 | +1.6% | 3.63% |
| State Street Corp | $376.5M | 710,895 | +4.2% | 2.51% |
| Geode Capital Management, LLC | $376.3M | 710,465 | -4.6% | 2.51% |
| Wasatch Advisors LP | $337.1M | 636,595 | -17.7% | 2.25% |
| Invesco Ltd. | $306.8M | 579,241 | +0.3% | 2.05% |
| Baillie Gifford & Co | $250.6M | 473,211 | -6.0% | 1.67% |
| Arrowstreet Capital, Limited Partnership | $227.2M | 429,012 | +8.4% | 1.52% |
| Renaissance Technologies LLC | $220.1M | 415,588 | -17.7% | 1.47% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in MEDP
20 disclosures of 21 on record · median 22d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| David Taylor | Stock | Purchase | $1,001 - $15,000 | +41.2%S&P +3.2% · vs S&P 500 +38.0% | May 15, 2026 | May 28, 2026 | 13d |
| David Taylor | Stock | Purchase | $1,001 - $15,000 | +31.1%S&P +10.6% · vs S&P 500 +20.6% | Feb 26, 2026 | Mar 6, 2026 | 8d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $15,001 - $50,000 | -5.1%S&P +10.1% · vs S&P 500 -15.2% | Jan 15, 2026 | Feb 13, 2026 | 29d |
| David Taylor | Stock | Purchase | $1,001 - $15,000 | -1.1%S&P +9.8% · vs S&P 500 -10.9% | Jan 29, 2026 | Feb 2, 2026 | 4d |
| David Taylor | Stock | Sale | $1,001 - $15,000 | -4.0%S&P +10.2% · vs S&P 500 -14.2% | Jan 16, 2026 | Feb 2, 2026 | 17d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +13.0%S&P +13.6% · vs S&P 500 -0.5% | Oct 9, 2025 | Nov 18, 2025 | 40d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +34.4%S&P +21.0% · vs S&P 500 +13.4% | Aug 4, 2025 | Sep 12, 2025 | 39d |
| David Taylor | Stock | Sale | $1,001 - $15,000 | +34.0%S&P +20.3% · vs S&P 500 +13.8% | Jul 23, 2025 | Sep 2, 2025 | 41d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +28.7%S&P +20.2% · vs S&P 500 +8.5% | Jul 24, 2025 | Aug 14, 2025 | 21d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +21.7%S&P +21.5% · vs S&P 500 +0.2% | Jul 22, 2025 | Aug 13, 2025 | 22d |
| Robert BresnahanJoint | Stock | Sale | $1,001 - $15,000 | +66.6%S&P +31.1% · vs S&P 500 +35.5% | Jan 13, 2025 | Feb 13, 2025 | 31d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +53.7%S&P +40.1% · vs S&P 500 +13.6% | Jul 26, 2024 | Aug 15, 2024 | 20d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +45.1%S&P +39.7% · vs S&P 500 +5.4% | Jun 21, 2024 | Jul 9, 2024 | 18d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +97.7%S&P +57.2% · vs S&P 500 +40.6% | Jan 24, 2024 | Feb 15, 2024 | 22d |
| Michael GuestSpouse | Stock | Purchase | $1,001 - $15,000 | +112.5%S&P +73.3% · vs S&P 500 +39.2% | Nov 13, 2023 | Dec 11, 2023 | 28d |
| Josh Gottheimer | Stock | Sale | $1,001 - $15,000 | +263.3%S&P +92.9% · vs S&P 500 +170.3% | Jul 22, 2022 | Aug 29, 2022 | 38d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +175.2%S&P +67.2% · vs S&P 500 +108.0% | Oct 26, 2021 | Nov 15, 2021 | 20d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +318.2%S&P +108.0% · vs S&P 500 +210.2% | Dec 10, 2020 | Jan 11, 2021 | 32d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +322.1%S&P +106.0% · vs S&P 500 +216.1% | Dec 8, 2020 | Jan 7, 2021 | 30d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +425.3%S&P +131.1% · vs S&P 500 +294.1% | Oct 29, 2020 | Nov 5, 2020 | 7d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
3 members · estimate, as of Sep 10, 20263 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| David Taylor | Republican · House | $15,001 - $50,000 | 1.5% |
| Josh Gottheimer | Democrat · House | $1,001 - $15,000 | <0.1% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $1,001 - $15,000 | <0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded MEDP?
David Taylor, Gilbert Ray Cisneros, Jr., Lisa C. McClain, Robert Bresnahan, Josh Gottheimer, Michael Guest disclosed MEDP transactions in the filings shown here.
Which members of Congress hold MEDP?
3 members of Congress report a position in MEDP in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to David Taylor, Josh Gottheimer and Gilbert Ray Cisneros, Jr.. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are MEDP trades disclosed?
Congressional disclosures took a median of 22 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.